Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus

Abstract

Validated biomarkers and surrogate markers are badly needed for monitoring patients with systemic lupus erythematosus (SLE), both for routine clinical care and for clinical trials research. SLE is difficult to study in clinical trials, in part because the disease is so heterogeneous. Very few useful markers have been identified, and even those that historicallyhave been thought to be valid have been recently questioned. This report will focus on the use of emerging multiplexed assay formats that enable analysis of hundreds or even thousands of analytes simultaneously. Their potential and pitfalls for monitoring patients with SLE, particularly those enrolled in clinical trials testing novel therapeutics, will be discussed.

Keywords

biomarkers clinical trials multiplexed assays SLE surrogate markers

Get full access to this article

View all access options for this article.

References

Lupus Foundation of America website, http://www.lupus.org/education/stats.html2003. Last accessed 20 April 2004.

Tan E , Cohen A , Fries J et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1272-1277 .

Russo G , Zegar C , Giordano A. Advantages and limitations of micro-array technology in human cancer . Oncogene 2003; 22: 6497-6507 .

Lock C , Hermans G , Pedotti et al. Gene microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis . Nature Med 2002; 8: 500-508 .

Ramanathan M , Weinstock-Guttman B , Nguyen et al. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting patients compared with normal subjects . J Neuroimmunol 2001; 116: 213-219 .

Wandinger K , Sturzebecher C , Bielekova B et al. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes . Ann Neurol 2001; 50: 349-357 .

Ruschpler P , Lorenz P , Eichler W et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis . Arthritis Res Ther 2003; 5: R241-R252 .

Gallagher J , Howlin J , McCarthy C et al. Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide arrays . FEBS Letters 2003; 551: 8-12 .

van der Pouw Kraan T , van Gaalen F , Huizinga T , Pieterman E , Breedveld F , Verweij C. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair . Genes Immun 2003; 4: 187-196 .

10.

van der Pouw Kraan T , van Gaalen F , Kasperkovitz P et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues . Arthritis Rheum 2003; 48: 2132-2145 .

11.

Tezak Z , Hoffman E , Lutz J et al. Gene expression profiling in DQA1* 0501+ children with untreated dermatomyositis: a novel model of pathogenesis . J Immunol 2002; 168: 4154-4163 .

12.

Baechler E , Batliwalla F , Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus . Proc Natl Acad Sci, USA 2003; 100: 2610-2615 .

13.

Bennett L , Palucka A , Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood . J Exp Med 2003; 197: 711-723 .

14.

Maas K , Chan S , Parker J et al. Cutting edge: molecular portrait of human autoimmune disease . J Immunol 2002; 169: 5-9 .

15.

Rus V , Atamas S , Shustova V et al. Expression of cytokine and chemokine related genes in peripheral blood mononuclear cells from lupus patients by cDNA array . Clin Immunol 2002; 102: 283-290 .

16.

Rozzo S , Allard J , Choubey D et al. Evidence for an interferoninducible gene, Ifi202, in the susceptibility to systemic lupus . Immunity 2001; 15: 435-443 .

17.

Crow M , Wohlgemuth J. Microarray analysis of gene expression in lupus . Arthritis Res Ther 2003; 5: 279-287 .

18.

Thibault D , Utz PJ. Interpreting interest in interferon alpha . Arthritis Res Ther 2003; 5: 246-248 .

19.

von Mühlen CA , Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases . Semin Arthritis Rheum 1995; 24: 323-358 .

20.

Li N , Aoki V , Hans-Filho G , Rivitti E , Diaz L. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (Fogo Selvagem) . J Exp Med 2003; 197: 1501-1510 .

21.

Arbuckle M , McClain M , Rubertone M et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus . N Engl J Med 2003; 349: 1526-1533 .

22.

James J , Harley J. B-cell epitope spreading in autoimmunity . Immunol Rev 1998; 164: 185-200 .

23.

Joos T , Schrenk M , Hopfl P et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics . Electrophoresis 2000; 21: 2641-2650 .

24.

Hueber W , Utz PJ , Steinman L , Robinson W. Autoantibody profiling for the study and treatment of autoimmune disease . Arthritis Res 2002; 4: 290-295 .

25.

Robinson W , Steinman L , Utz PJ. Proteomics technologies for the study of autoimmune disease . Arthritis Rheum 2002; 46: 885-893 .

26.

Robinson W , Steinman L , Utz PJ. Protein arrays for autoantibody profiling and fine specificity mapping . Proteomics 2003; 11: 2077-2084 .

27.

Robinson W , DiGennaro C , Hueber W et al. Autoantigen microarrays for multiplex characterization of autoantibody responses . Nature Med 2002; 8: 295-301 .

28.

Robinson W , Fontoura P , Lee B et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis . Nat Biotech 2003; 21: 1033-1039 .

29.

Sercarz E. Arraying autoimmunity treatment . Nature Biotech 2003; 21: 1017-1019 .

30.

de Vegvar H , Amara R , Steinman L , Utz PJ , Robinson H , Robinson W. Microarray profiling of antibody responses against Simian-Human Immunodeficiency Virus: postchallenge convergence of reactivities independentof host histocompatibility type and vaccine regimen . J Virol 2003; 77: 11125-11138 .

31.

Ghanekar S , Maecker H. Cytokine flow cytometry: multiparametric approach to immune function analysis . Cytotherapy 2003; 5: 1-6 .

32.

Tam S , Wiese R , Lee S , Gilmore J , Kumble K. Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays . J Immunol Meth 2002; 261: 157-165 .

33.

Lin Y , Huang R , Cao X , Wang S , Shi Q , Huang R. Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate . Clin Chem Lab Med 2003; 41: 139-145 .

34.

Keller K , Kalwar R , Dubois K , Crouse D , Chafin W , Kane B. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants . Cytometry 2001; 45: 27-36 .

35.

Chan-Hui P-Y , Stephens K , Singh S. Applications of the eTag assay platform to systems biology approaches to clinical immunology studies . Clin Immunol 2004; in press.

36.

Xue Q , Wainright A , Gangakhedkar S , Gibbons I. Multiplexed enzyme assays in capillary electrophoretic single-use microfluidic devices . Electrophoresis 2001; 22: 4000-4007 .

37.

Tsokos G , Nambiar M , Tenbrock K , Juang Y-T. Rewiring the T cell; signaling defects and novel prospects for the treatment of SLE . Trends Immunol 2003; 24: 259-263 .

38.

Tsokos G , Liossis S-N. Immune cell signaling defects in lupus: activation, anergy, and death . Immunol Today 1999; 20: 119-124 .

39.

Huck S , Le Corre R , Youinou P , Zouali M. Expression of B cell receptor associated signaling molecules in human lupus . Autoimmun 2001; 33: 213-224 .

40.

Enyedy E , Nambiar M , Liossis S , Dennis G , Kammer G , Tsokos G. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus . Arthritis Rheum 2001; 44: 1114-1121 .

41.

Liossis S , Solomou E , Dimopoulos M , Panayiotidis P , Mavrikakis M , Sfikakis P. B cell kinase lyn deficiency in patients with systemic lupus erythematosus . J Investig Med 2001; 49: 157-165 .

42.

Grolleau A , Kaplan M , Hanash S , Beretta L , Richardson B. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients . J Clin Invest 2000; 106: 1561-1568 .

43.

Kammer G. Deficient protein kinase A in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction . Ann NY Acad Sci 2002; 968: 96-105 .

44.

Monneaux F, Muller S. Altered expression of proteins in signaling, apoptosis, and autoantigen posttranslational modifications in MRL/lpr lupus mice. Personal communication.

45.

Lorenz P , Ruschpler P , Koczan D , Stiehl P , Thiesen H. From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies . Proteomics 2003; 3: 991-1002 .

46.

Perez O , Nolan G. Simultaneous measurement of multiple active kinase states usingpolychromaticflowcytometry . Nat Biotech 2002; 20: 155-162 .

47.

Haab B , Dunham M , Brown P. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions . Genome Biology 2001; 2: RESEARCH2004.1. http://www.genomebio.com last accessed 20 March 2004.

48.

Petricoin E , Zoon K , Kohn E , Barrett J , Liotta L. Clinical proteomics: translating benchside promise into bedside reality . Nature Rev 2002; 1: 683-695 .

49.

Soen Y , Chen D , Kraft D , Davis M , Brown P. Detection and characterization of cellular immune responses using peptide-MHC microarrays . PLoS Bio 2003; 1: E65-E65 .